Abstract
The ubiquitin-proteasome pathway has emerged as a central player in the regulation of several diverse cellular processes. Here, we describe the important components of this complex biochemical machinery as well as several important cellular substrates targeted by this pathway and examples of human diseases resulting from defects in various components of the ubiquitin-proteasome pathway. In addition, this review covers the chemistry of synthetic and natural proteasome inhibitors, emphasizing their mode of actions toward the 20S proteasome. Given the importance of proteasome-mediated protein degradation in various intracellular processes, inhibitors of this pathway will continue to serve as both molecular probes of major cellular networks as well as potential therapeutic agents for various human diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 245-273 |
| Number of pages | 29 |
| Journal | Medicinal Research Reviews |
| Volume | 21 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2001 |
Funding
| Funders | Funder number |
|---|---|
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | R01GM062120 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Natural product
- Proteasome inhibitor
- Protein degradation
- Ubiquitin-proteasome pathway
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
- Drug Discovery
Fingerprint
Dive into the research topics of 'The ubiquitin-proteasome pathway and proteasome inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver